Investigated factors have frequently included age, sex, histologic subtype, tumor stage, tumor site, performance status, and treatment approaches, as well as laboratory parameters and biomarkers such as white blood cell counts, platelet counts, CRP, fibrinogen, albumin, activin A, and combined inflammatory markers of those [9,17,18,19,20,49]. This evidence concerns the gene ALB and neoplasm.